Structure and signalling in the IL-17 receptor family
Open accessThe DOI matches its Crossref record; 111 of the 111 references it cites were found in a registry or an index.
Abstract
Interleukin-17A (IL-17A), the hallmark cytokine of the newly defined T helper 17 (T(H)17) cell subset, has important roles in protecting the host against extracellular pathogens, but also promotes inflammatory pathology in autoimmune disease. IL-17A and its receptor (IL-17RA) are the founding members of a newly described family of cytokines and receptors that have unique structural features which distinguish them from other cytokine families. Research defining the signal transduction pathways induced by IL-17R family cytokines has lagged behind that of other cytokine families, but studies in the past 2 years have begun to delineate unusual functional motifs and new proximal signalling mediators used by the IL-17R family to mediate downstream events.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“most documented IL-17R signaling occurs in non-hematopoietic cells, particularly cells of epithelial and mesenchymal origin [44,45].”
From The Kallikrein-Kinin System: A Novel Mediator of IL-17-Driven Anti-Candida Immunity in the Kidney (2016) · cites this paper as [44]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mosmann, T. R., Cherwinski, H., Bond, M. W., Giedlin, M. A., & Coffman, R. L. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.7.2348 · Cited by 7,506
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992
Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J., & Littman, D. R. (2006) · Cell · doi:10.1016/j.cell.2006.07.035 · Cited by 5,145
Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099
Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605
Transforming growth factor-β induces development of the TH17 lineage
Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., Hatton, R. D., Wahl, S. M., Schoeb, T. R., & Weaver, C. T. (2006) · Nature · doi:10.1038/nature04754 · Cited by 3,087
A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene
Duerr, R. H., Taylor, K. D., Brant, S. R., Rioux, J. D., Silverberg, M. S., Daly, M. J., Steinhart, A. H., Abraham, C., Regueiro, M., Griffiths, A., et al. (2006) · Science · doi:10.1126/science.1135245 · Cited by 3,039
Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T., et al. (2003) · Nature · doi:10.1038/nature01355 · Cited by 2,906
Cited by
Items 301–400 of 1,001
Eddens, T. J., Elsegeiny, W. A. W., García-Hernández, M. D. L. L., Castillo, P., Trevejo-Nuñez, G., Serody, K., Campfield, B. T., Khader, S. A., Chen, K., Rangel‐Moreno, J., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.03.016 · Cited by 90
IL-17B: A new area of study in the IL-17 family
Bie, Q., Jin, C., Zhang, B., & Dong, H. (2017) · Molecular Immunology · doi:10.1016/j.molimm.2017.07.004 · Cited by 87
The Emerging Role of the IL-17B/IL-17RB Pathway in Cancer
Bastid, J., Déjou, C., Docquier, A., & Bonnefoy, N. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00718 · Cited by 88
“IL-17RB is expressed in various endocrine tissues and in epithelial cells in different organs such as kidney and liver and mucosal tissues (8, 19, 21).”
BackgroundCytokines: Can Cancer Get the Message?
Morris, R. M., Mortimer, T. O., & O'Neill, K. L. (2022) · Cancers · doi:10.3390/cancers14092178 · Cited by 110
Borowczak, J., Szczerbowski, K., Maniewski, M., Kowalewski, A., Janiczek-Polewska, M., Szylberg, A., Marszałek, A., & Szylberg, Ł. (2022) · Biomedicines · doi:10.3390/biomedicines10071670 · Cited by 99
Nadeem, A., Ahmad, S. F., Attia, S. M., Bakheet, S. A., Al-Harbi, N. O., & AL-Ayadhi, L. Y. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.09.010 · Cited by 95
Bougarn, S., Cunha, P., Gilbert, F. B., Harmache, A., Foucras, G., & Rainard, P. (2011) · Cytokine · doi:10.1016/j.cyto.2011.09.020 · Cited by 100
Storelli, E., Cassina, N., Rasini, E., Marino, F., & Cosentino, M. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00013 · Cited by 84
“In addition, soluble IL-17R subunits have been evaluated in pre-clinical models (38).”
BackgroundInfluentialStructure of IL-17A in Complex with a Potent, Fully Human Neutralizing Antibody
Gerhardt, S., Abbott, W. M., Hargreaves, D., Pauptit, R. A., Davies, R. A., Needham, M., Langham, C., Barker, W., Aziz, A., Snow, M. J., et al. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.10.008 · Cited by 89
Chattha, K. S., Vlasova, A. N., Kandasamy, S., Rajashekara, G., & Saif, L. J. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300678 · Cited by 90
“and NKT cells, which may have contributed to the increased serum IL-17 in our study (63).”
BackgroundInhibition of T-cell activity in alopecia areata: recent developments and new directions
Passeron, T., King, B., Sénéschal, J., Steinhoff, M. S., Jabbari, A., Ohyama, M., Tobin, D. J., Randhawa, S., Winkler, A. R., Telliez, J., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1243556 · Cited by 92
“Although IL-17 primarily signals through a JAK-independent pathway (116), most of the cytokines described here signal through JAKs (Figure 3) (92, 94).”
BackgroundFriedrich, M., Diegelmann, J., Schauber, J., Auernhammer, C. J., & Brand, S. (2014) · Mucosal Immunology · doi:10.1038/mi.2014.124 · Cited by 91
IL-17A Synergistically Enhances Bile Acid–Induced Inflammation during Obstructive Cholestasis
O'Brien, K. M., Allen, K. M., Rockwell, C. E., Towery, K., Luyendyk, J. P., & Copple, B. L. (2013) · The American Journal of Pathology · doi:10.1016/j.ajpath.2013.07.019 · Cited by 82
Interleukin-17A Promotes CD8 + T Cell Cytotoxicity To Facilitate West Nile Virus Clearance
Acharya, D., Wang, P., Paul, A. M., Dai, J., Gate, D., Lowery, J. E., Stokić, D. S., Leis, A. A., Flavell, R. A., Town, T., et al. (2016) · Journal of Virology · doi:10.1128/jvi.01529-16 · Cited by 88
“essential upstream activator of the classical NF- B pathway called TRAF6 (64).”
BackgroundRole of IL-17 family cytokines in the progression of IPF from inflammation to fibrosis
Nie, Y., Wu, S., Xuan, Y.-H., & Yan, G. (2022) · Military Medical Research · doi:10.1186/s40779-022-00382-3 · Cited by 103
Kitami, S., Tanaka, H., Kawato, T., Tanabe, N., Katono, T., Zhang, F., Suzuki, N., Yonehara, Y., & Maeno, M. (2010) · Biochimie · doi:10.1016/j.biochi.2009.12.011 · Cited by 102
IRF4 and its regulators: evolving insights into the pathogenesis of inflammatory arthritis?
Biswas, P. S., Bhagat, G., & Pernis, A. B. (2010) · Immunological Reviews · doi:10.1111/j.0105-2896.2009.00864.x · Cited by 81
Th17 cytokines and host-pathogen interactions at the mucosa: Dichotomies of help and harm
Liu, J. Z., Pezeshki, M., & Raffatellu, M. (2009) · Cytokine · doi:10.1016/j.cyto.2009.07.005 · Cited by 92
“Receptors for IL-17A and IL-17F (Il-17Ra and IL-17Rc) are present in several cell types, including antigen presenting cells and epithelial cells [18,19].”
BackgroundRaised interleukin-17 is immunolocalised to neutrophils in cystic fibrosis lung disease
Brodlie, M., McKean, M. C., Johnson, G. E., Anderson, A. E., Hilkens, C. M. U., Fisher, A. J., Corris, P. A., Lordan, J. L., & Ward, C. (2011) · European Respiratory Journal · doi:10.1183/09031936.00067110 · Cited by 81
Buckley, K. M., Ho, E. C. H., Hibino, T., Schrankel, C. S., Schuh, N. W., Wang, G., & Rast, J. P. (2017) · eLife · doi:10.7554/elife.23481 · Cited by 77
“As in other systems, these receptors may be widely expressed at low levels (Gaffen, 2009).”
BackgroundLombard, R., Doz, E., Carreras, F., Epardaud, M., Vern, Y. L., Buzoni–Gatel, D., & Winter, N. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149455 · Cited by 93
“IL-17RA is expressed ubiquitously, and particularly in non hematopoietic epithelial cells, endothelial cells and fibroblasts [14].”
BackgroundInfluentialZhou, J., An, X., Dong, J., Wang, Y., Zhong, H., Duan, L., Ling, J., Ping, F., & Shang, J. (2018) · The FASEB Journal · doi:10.1096/fj.201701242rr · Cited by 85
“IL-17 signals viaNF-kB,MAPK, and PI3K signaling pathways (42).”
BackgroundIL‐17 and its role in inflammatory, autoimmune, and oncological skin diseases: state of art
Bernardini, N., Skroza, N., Tolino, E., Mambrin, A., Anzalone, A., Balduzzi, V., Colapietra, D., Marchesiello, A., Michelini, S., Proietti, I., et al. (2019) · International Journal of Dermatology · doi:10.1111/ijd.14695 · Cited by 88
Interleukin‐17 and ischaemic stroke
Zhang, Q., Liao, Y., Liu, Z., Dai, Y., Li, Y., Li, Y., & Tang, Y. (2020) · Immunology · doi:10.1111/imm.13265 · Cited by 88
Epithelial Cells and Innate Antifungal Defense
Weindl, G., Wagener, J., & Schaller, M. (2010) · Journal of Dental Research · doi:10.1177/0022034510368784 · Cited by 79
Pain in Rheumatoid Arthritis: Models and Mechanisms
Bas, D. B., Su, J., Wigerblad, G., & Svensson, C. I. (2016) · Pain Management · doi:10.2217/pmt.16.4 · Cited by 99
IL-25 and IL-25 Receptor Expression on Eosinophils from Subjects with Allergic Asthma
Tang, W., Smith, S. G., Beaudin, S., Dua, B., Howie, K. J., Gauvreau, G. M., & O’Byrne, P. M. (2013) · International Archives of Allergy and Immunology · doi:10.1159/000355331 · Cited by 88
Andrew, D. W., Cochrane, M., Schripsema, J. H., Ramsey, K. H., Dando, S. J., O’Meara, C. P., Timms, P., & Beagley, K. W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076664 · Cited by 85
“Whilst the current view is that IL-17rc cannot induce signalling in the absence of IL-17ra [64] there are known to be many splice isoforms of IL-17rc and the tissue expression pattern of IL-17rc is different to that of IL-17ra, being low in hematopoietic cells but higher in non-immune cells [65].”
BackgroundInfluentialWu, N., Wang, Y., Wang, K., Zhong, B., Liao, Y., Liang, J., & Jiang, N. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05215-8 · Cited by 85
Freches, D., Korf, H., Denis, O., Havaux, X., Huygen, K., & Romano, M. (2013) · Immunology · doi:10.1111/imm.12130 · Cited by 93
IL-17 Contributes to Cell-Mediated Defense against Pulmonary Yersinia pestis Infection
Lin, J., Kummer, L. W., Szaba, F. M., & Smiley, S. T. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1003303 · Cited by 77
Increased circulating interleukin-17 levels in preeclampsia
Molvarec, A., Czegle, I., Szijártó, J., & Rigó, J. J. (2015) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2015.05.007 · Cited by 86
“There are six members of the interleukin (IL)-17-family of cytokines (IL-17A, IL-17B, IL-17C, IL-17D, IL-17E [IL-25], and IL-17F), while the IL-17 receptor family comprises five receptor subunits (IL-17RA, IL-17RB/IL-25R, IL-17RC, IL-17RD/SEF, and IL-17RE) (Gaffen 2009).”
BackgroundIL ‐17A promotes neutrophilic inflammation and disturbs acute wound healing in skin
Takagi, N., Kawakami, K., Kanno, E., Tanno, H., Takeda, A., Ishii, K., Imai, Y., Iwakura, Y., & Tachi, M. (2016) · Experimental Dermatology · doi:10.1111/exd.13115 · Cited by 87
New Targeted Therapies for Uncontrolled Asthma.
Corren, J. (2019) · Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2019.03.022 · Cited by 73
Cytokine Signaling in Diabetic Neuropathy: A Key Player in Peripheral Nerve Damage
Nashtahosseini, Z., Eslami, M., Paraandavaji, E., Haraj, A., Dowlat, B. F., Hosseinzadeh, E., Oksenych, V., & Naderian, R. (2025) · Biomedicines · doi:10.3390/biomedicines13030589 · Cited by 94
“IL-17, a hallmark cytokine of T helper 17 cells, specifically its type A form, activates the MAPK pathway, stimulating IL-8 secretion [32,33] and up-regulating COX-2 expression [32].”
Jain, P., Javdan, M., Feger, F., Chiu, P., Sison, C., Damle, R. N., Bhuiya, T., Şen, F., Abruzzo, L. V., Burger, J. A., et al. (2011) · Haematologica · doi:10.3324/haematol.2011.047316 · Cited by 83
“IL-17A is one of six members (A-F) of the IL-17 family.(6) A corresponding IL 17 receptor family of five members (AE) exists.”
BackgroundCurrent Concepts in Psoriatic Arthritis: Pathogenesis and Management
de Vlam, K., Gottlieb, A. B., & Mease, P. J. (2014) · Acta Dermato Venereologica · doi:10.2340/00015555-1833 · Cited by 87
Goepfert, A., Lehmann, S., Blank, J., Kolbinger, F., & Rondeau, J.-M. (2020) · Immunity · doi:10.1016/j.immuni.2020.02.004 · Cited by 75
Interleukin-17A Interweaves the Skeletal and Immune Systems
Tang, M., Lu, L., & Yu, X. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.625034 · Cited by 86
“IL-17RA includes two extracellular fibronectin II-like domains and two intracellular “SEFIR” domains (25, 26).”
BackgroundCurrent views on the functions of interleukin-17A-producing cells in atherosclerosis
Butcher, M. J., & Galkina, E. (2011) · Thrombosis and Haemostasis · doi:10.1160/th11-05-0342 · Cited by 83
“In addition to these domains, IL-17RA is unique amongst the IL-17R family members in that it possesses Toll IL-1 receptor-like BB-loop (TILL) and C/EBPβ activation domain (CBAD) motifs (reviewed in [29]).”
BackgroundExpression of IL-33 in the epidermis: The mechanism of induction by IL-17
Meephansan, J., Komine, M., Tsuda, H., Karakawa, M., Tominaga, S., & Ohtsuki, M. (2013) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2013.04.014 · Cited by 85
T cells, teeth and tissue destruction – what do T cells do in periodontal disease?
Campbell, L., Millhouse, E., Malcolm, J., & Culshaw, S. (2015) · Molecular Oral Microbiology · doi:10.1111/omi.12144 · Cited by 90
Gao, H., Liu, L., Zhao, Y., Hara, H., Chen, P., Xu, J., Tang, J., Wei, L., Li, Z., Cooper, D. K. C., et al. (2017) · Xenotransplantation · doi:10.1111/xen.12291 · Cited by 74
Blocking IL-17: A Promising Strategy in the Treatment of Systemic Rheumatic Diseases
Rafael‐Vidal, C., Pérez, N., Altabás‐González, I., García, S., & Pego‐Reigosa, J. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197100 · Cited by 83
Roles of IL-25 in Type 2 Inflammation and Autoimmune Pathogenesis
Deng, C., Peng, N., Tang, Y., Yu, N., Wang, C., Cai, X., Zhang, L., Hu, D., Ciccia, F., & Lu, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.691559 · Cited by 81
“IL-17R subunits from both mouse and human range in size from 272 to 866 amino acids and contain full-length forms and smaller alternatively spliced isoforms (36).”
BackgroundThe Role of IL-17 Cytokines in Psoriasis
Mosca, M., Hong, J. J., Hadeler, E. K., Hakimi, M., Liao, W. J., & Bhutani, T. (2021) · Dove Medical Press (Taylor and Francis Group) · Cited by 73
Hot, A., Zrioual, S., Toh, M., Lenief, V., & Miossec, P. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.132233 · Cited by 75
“The hallmark of the Th17 subset is the production of interleukin (IL)-17A and IL-17F, which share strong homology. Although studies have shown the pathogenic implications of the IL-17 axis in mouse models of RA, our knowledge concerning IL-17F and, to a lesser extent, IL-17A remains limited in human pathology. In part…”
BackgroundInterleukin-17-induced protein lipocalin 2 is dispensable for immunity to oral candidiasis
Ferreira, M. C., Whibley, N., Mamo, A. J., Siebenlist, U., Chan, Y. R., & Gaffen, S. L. (2014) · Infection and Immunity · doi:10.1128/iai.01389-13 · Cited by 72
“IL-17 signaling induces a program of gene expression associated with innate immune responses, including cytokines (IL-6, granulocyte colonystimulating factor [G-CSF]), chemokines (CXCL1, CXCL2, CCL20), and antimicrobial peptides ( -defensins and S100A8/9) (13).”
BackgroundSelf-citationHu, Z., Luo, D., Wang, D., Ma, L., Zhao, Y., & Li, L. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000484390 · Cited by 77
Advances in the study of IL-17 in neurological diseases and mental disorders
Lu, Y., Zhang, P., Xu, F., Zheng, Y., & Zhao, H. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1284304 · Cited by 82
“IL-17RA, a co-receptor common to the IL-17 family of ligands, is the most critical among them (10).”
BackgroundIL-17 in wound repair: bridging acute and chronic responses
Mu, X., Gu, R., Tang, M., Wu, X., He, W., & Nie, X. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01668-w · Cited by 85
“There are connections between the IL-17 signaling pathway and immunopathology, as well as autoimmune disorders and the advancement of cancer [18].”
BackgroundLathrop, M. J., Brooks, E. M., Nick, B., Sokocevic, D., Borg, Z. D., Goodwin, M., Loi, R., Cruz, F. F., Dunaway, C. W., Steele, C. H., et al. (2014) · Stem Cells Translational Medicine · doi:10.5966/sctm.2013-0061 · Cited by 73
Kang, Z., Swaidani, S., Yin, W., Wang, C., Barlow, J. L., Gulen, M. F., Bulek, K., Do, J.-S., Aronica, M., McKenzie, A. N. J., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.03.021 · Cited by 72
“IL-17 receptor (IL-17RAand IL-17RC) and IL-25R (IL-17RBand IL-17RA) belong to a newly defined SEFIR protein family, resulting from a conserved sequence segment called SEFIR in their cytoplasmic domain (Novatchkova et al., 2003).”
BackgroundWu, N., Huang, D.-Y., Tsou, H.-N., Lin, Y., & Lin, W. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.383 · Cited by 76
Hagforsen, E., Hedstrand, H., Nyberg, F., & MICHAELSSON, G. (2010) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2010.09819.x · Cited by 73
TPL2 mediates autoimmune inflammation through activation of the TAK1 axis of IL-17 signaling
Xiao, Y., Jin, J., Chang, M., Nakaya, M., Hu, H., Zou, Q., Zhou, X., Brittain, G. C., Cheng, X., & Sun, S.-C. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20132640 · Cited by 71
“IL-17 is the prototypical member of a family of related cytokines and has been linked to the pathogenesis of both MS and other autoimmune diseases (Gaffen, 2009; Iwakura et al., 2011; Zepp et al., 2011; Song and Qian, 2013).”
BackgroundTh17/IL-17 induces endothelial cell senescence via activation of NF-κB/p53/Rb signaling pathway
Zhang, L., Liu, M., Liu, W., Hu, C., Li, H., Deng, J., Cao, Q., Wang, Y., Hu, W., & Li, Q. (2021) · Laboratory Investigation · doi:10.1038/s41374-021-00629-y · Cited by 87
Social anxiety disorder-associated gut microbiota increases social fear
Ritz, N. L., Brocka, M., Butler, M., Cowan, C. S. M., Barrera-Bugueño, C., Turkington, C. J. R., Draper, L. A., Bastiaanssen, T. F. S., Turpin, V., Morales, L., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2308706120 · Cited by 91
Brackett, C. M., Muhitch, J. B., Evans, S. S., & Gollnick, S. O. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1103621 · Cited by 81
“We thank Amgen (Thousand Oaks, CA) for the generous gift of the anti-mouse IL-17A Abs.”
BackgroundInfluentialParticipation of interleukin 17A in neuroimmune interactions
Moynes, D. M., Vanner, S. J., & Lomax, A. E. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.03.004 · Cited by 74
Compartmentalized Expression of Th1 and Th17 Cytokines in Pediatric Inflammatory Bowel Diseases
Verdier, J., Begue, B., Cerf-Bensussan, N., & Ruemmele, F. M. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21905 · Cited by 71
The role of IL17B-IL17RB signaling pathway in breast cancer
Alinejad, V., Dolati, S., Motallebnezhad, M., & Yousefi, M. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.01.120 · Cited by 78
Mechanistic rationales for targeting interleukin-17A in spondyloarthritis
Raychaudhuri, S. P., & Raychaudhuri, S. K. (2017) · Arthritis Research & Therapy · doi:10.1186/s13075-017-1249-5 · Cited by 75
“as well as with mucocutaneous defense mechanisms against extracellular pathogens [8, 12, 14, 17, 18].”
BackgroundPathophysiology of Atopic Dermatitis and Psoriasis: Implications for Management in Children
Chovatiya, R., & Silverberg, J. I. (2019) · Children · doi:10.3390/children6100108 · Cited by 87
Alarmin cytokines as central regulators of cutaneous immunity
Hasegawa, T., Oka, T., & Demehri, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.876515 · Cited by 70
“Expression of IL-25R has been reported on non-immune cells, including fibroblasts and endothelial cells, and immune cells, such as Th2 cells, natural killer T cells (NKT cells), DCs, macrophages, ILC2s, mast cells, basophils, and eosinophils in the inflammatory state (115, 116).”
BackgroundInterleukin‐17—A multifaceted cytokine in viral infections
Sahu, U., Biswas, D., Prajapati, V. K., Singh, A. K., Samant, M., & Khare, P. S. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30471 · Cited by 80
“The inflammatory response produced by IL‐17 triggers the migration and accumulation of neutrophils at the site of infection (Gaffen, 2009).”
BackgroundOrphan receptor IL-17RD tunes IL-17A signalling and is required for neutrophilia
Mellett, M., Atzei, P., Horgan, A., Hams, E., Floß, T., Wurst, W., Fallon, P. G., & Moynagh, P. N. (2012) · Nature Communications · doi:10.1038/ncomms2127 · Cited by 80
Fiocco, U., Accordi, B., Martini, V., Oliviero, F., Facco, M., Cabrelle, A., Piva, L., Molena, B., Caso, F., Costa, L., et al. (2014) · Immunologic Research · doi:10.1007/s12026-013-8481-0 · Cited by 72
“The IL-17A and IL-17F homo–heterodimers of the pleiotropic IL-17 cytokine (CK) family (IL-17A through IL-17F CKs and receptors IL-17RA through RE) share the IL-17A and IL-17C heterodimeric receptor complex [7].”
BackgroundIL-17C Is a Mediator of Respiratory Epithelial Innate Immune Response
Pfeifer, P., Voss, M., Wonnenberg, B., Hellberg, J., Seiler, F., Lepper, P. M., Bischoff, M., Langer, F., Schäfers, H., Menger, M. D., et al. (2012) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2012-0232oc · Cited by 75
Renal IL-17 expression in human ANCA-associated glomerulonephritis
Velden, J., Paust, H., Hoxha, E., Turner, J., Steinmetz, O. M., Wolf, G., Jabs, W. J., Özcan, F., Beige, J., Heering, P., et al. (2012) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00683.2011 · Cited by 75
Yin and yang of interleukin-17 in host immunity to infection
Das, S., & Khader, S. A. (2017) · F1000Research · doi:10.12688/f1000research.10862.1 · Cited by 78
“The IL-17 cytokine family employs various cytokine receptors (IL-17RA, IL-17RB, IL-17RC, IL-17RD, and IL-17RE) on target cells to mediate their biological functions 5 .”
BackgroundAcute graft-versus-host disease is regulated by an IL-17–sensitive microbiome
Varelias, A., Ormerod, K. L., Bunting, M. D., Koyama, M., Gartlan, K. H., Kuns, R. D., Lachner, N., Locke, K. R., Lim, C. Y., Henden, A. S., et al. (2017) · Blood · doi:10.1182/blood-2016-08-732628 · Cited by 70
A proinflammatory CD4+ T cell phenotype in gestational diabetes mellitus
Sheu, A., Chan, Y., Ferguson, A. L., Bakhtyari, M. B., Hawke, W., White, C., Chan, Y. F., Bertolino, P., Woon, H. G., Palendira, U., et al. (2018) · Diabetologia · doi:10.1007/s00125-018-4615-1 · Cited by 76
HSP90 inhibitor geldanamycin reverts IL-13– and IL-17–induced airway goblet cell metaplasia
Pezzulo, A. A., Tudas, R. A., Stewart, C. G., Buonfiglio, L. G. V., Lindsay, B. D., Taft, P. J., Gansemer, N. D., & Zabner, J. (2019) · Journal of Clinical Investigation · doi:10.1172/jci123524 · Cited by 77
Th17 Differentiation and Their Pro-inflammation Function
Song, X., Gao, H., & Qian, Y. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-94-017-9487-9_5 · Cited by 74
“All receptor members harbor two fibronectin III-like domains in their extracellular region and a SEF/IL-17R (SEFIR) domain in their intracellular part [68].”
BackgroundNovel Biologicals for the Treatment of Allergic Diseases and Asthma
Tan, H.-T. T., Sugita, K., & Akdis, C. A. (2016) · Current Allergy and Asthma Reports · doi:10.1007/s11882-016-0650-5 · Cited by 68
The role of pro-inflammatory cytokines in lipid metabolism of metabolic diseases
Chen, Y., Yu, C., & Deng, W. (2019) · International Reviews of Immunology · doi:10.1080/08830185.2019.1645138 · Cited by 72
“IL-17 is actually a group of similar cytokines, which is composed of six cytokines (IL-17A to IL-17F) and five receptors (IL-17RA to IL-17RE) [16, 17].”
Samotij, D., Nedoszytko, B., Bartosińska, J., Batycka-Baran, A., Czajkowski, R., Dobrucki, I. T., Dobrucki, L. W., Górecka-Sokołowska, M., Janaszak‐Jasiecka, A., Krasowska, D., et al. (2020) · Advances in Dermatology and Allergology · doi:10.5114/ada.2020.94832 · Cited by 74
Viral Mimicry of Interleukin-17A by SARS-CoV-2 ORF8
Wu, X., Xia, T., Shin, W.-J., Yu, K.-M., Jung, W., Herrmann, A., Foo, S., Chen, W., Zhang, P., Lee, J., et al. (2022) · mBio · doi:10.1128/mbio.00402-22 · Cited by 82
The role of IL-17 in psoriasis
Malakouti, M., Brown, G. E., Wang, E., Koo, J. Y. M., & Levin, E. C. (2014) · Journal of Dermatological Treatment · doi:10.3109/09546634.2013.879093 · Cited by 81
“results in intermediate biologic activity (7).”
BackgroundZhang, L., Liu, R., Song, M., Hu, Y., Pan, B., Cai, J., & Wang, M. (2012) · Experimental Parasitology · doi:10.1016/j.exppara.2012.11.009 · Cited by 79
“differentiation is regulated by the transcription factors signal transducer and activator of transcription 3 (STAT-3), retinoic acid receptor-related orphan receptor-ct (RORct) and aryl hydrocarbon receptor, and is driven by transforming growth factor-b (TGF-b), IL1 and IL-6 (Gaffen, 2009).”
BackgroundThe paradoxical role of IL-17 in atherosclerosis
Gong, F., Liu, Z., Liu, J., Zhou, P., Liu, Y., & Lü, X. (2015) · Cellular Immunology · doi:10.1016/j.cellimm.2015.05.007 · Cited by 71
Evidence for anti‐inflammatory effects of C5a on the innate IL‐17A/IL‐23 axis
Bosmann, M., Sarma, J. V., Atefi, G., Zetoune, F. S., & Ward, P. A. (2012) · The FASEB Journal · doi:10.1096/fj.11-199216 · Cited by 67
IL-17 induces macrophages to M2-like phenotype via NF-κB
Shen, J., Sun, X., Pan, B., Cao, S., Cao, J., Che, D., Liu, F., Zhang, S., & Yu, Y. (2018) · Cancer Management and Research · doi:10.2147/cmar.s174899 · Cited by 74
Xu, J., Ma, H.-Y., Liu, X., Rosenthal, S., Baglieri, J., McCubbin, R., Sun, M., Koyama, Y., Geoffroy, C. G., Saijo, K., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.131277 · Cited by 66
Wu, S.-Y., Yu, J.-S., Liu, F., Miaw, S., & Wu‐Hsieh, B. A. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202122 · Cited by 76
Mancini, F., Monaci, E., Lofano, G., Torre, A., Bacconi, M., Tavarini, S., Sammicheli, C., Arcidiacono, L., Galletti, B., Laera, D., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147767 · Cited by 71
“TNF could also be important since it can not only synergize with IL-17A and IL-17F, which on their own are poor activators of signaling [44, 45], but also prime neutrophils, rendering them faster and more efficient against pathogens [46, 47].”
BackgroundThe Role of Interleukin-17 in Lung Cancer
Wu, F., Xu, J., Huang, Q., Han, J., Duan, L., Fan, J., Lv, Z., Guo, M., Hu, G., Chen, L., et al. (2016) · Mediators of Inflammation · doi:10.1155/2016/8494079 · Cited by 67
TH17 Cell and Epithelial Cell Crosstalk during Inflammatory Bowel Disease and Carcinogenesis
Kempski, J., Brockmann, L., Gagliani, N., & Huber, S. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01373 · Cited by 67
“World J Gastroenterol (2014) 20(48):18390–6.”
BackgroundTh17 cells regulate the production of CXCL1 in breast cancer
Ma, K., Yang, L., Shen, R., Kong, B., Chen, W., Liang, J., Tang, G., & Zhang, B. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.01.026 · Cited by 69
“In addition, Th17 cells recruit neutrophils and mediate the initial protection from pathogens during infections [34].”
BackgroundKusagaya, H., Fujisawa, T., Yamanaka, K., Mori, K., Hashimoto, D., Enomoto, N., Inui, N., Nakamura, Y., Wu, R., Maekawa, M., et al. (2014) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2013-0130oc · Cited by 73
Kocić, J., Santibanez, J. F., Krstić, J., Mojsilović, S. B., Djordjević, I. O., Trivanović, D. I., Ilić, V. L., & Bugarski, D. S. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.01.001 · Cited by 76
“Some of the most commonly studied pathways are the MAPKs [8,21].”
BackgroundBinding site elucidation and structure guided design of macrocyclic IL-17A antagonists
Liu, S., Dakin, L. A., Li, X., Withka, J. M., Sahasrabudhe, P. V., Li, W., Banker, M. E., Balbo, P., Shanker, S., Chrunyk, B. A., et al. (2016) · Scientific Reports · doi:10.1038/srep30859 · Cited by 69
Phosphorylation-dependent Regnase-1 release from endoplasmic reticulum is critical in IL-17 response
Tanaka, H., Arima, Y., Kamimura, D., Tanaka, Y., Takahashi, N., Uehata, T., Maeda, K., Satoh, T., Murakami, M., & Akira, S. (2019) · The Journal of Experimental Medicine · doi:10.1084/jem.20181078 · Cited by 79
“IL-17 activates both NF-κB and MAPK signaling pathways but is a weak activator of NF-κB (Gaffen, 2009).”
BackgroundCanavan, T. N., Elmets, C. A., Cantrell, W., Evans, J. M., & Elewski, B. E. (2015) · American Journal of Clinical Dermatology · doi:10.1007/s40257-015-0162-4 · Cited by 72
Role of Th17 Cytokines in Airway Remodeling in Asthma and Therapy Perspectives
Margelidon-Cozzolino, V., Tsicopoulos, A., Chenivesse, C., & de Nadaï, P. (2022) · Frontiers in Allergy · doi:10.3389/falgy.2022.806391 · Cited by 77
Hmgb1-IL-23-IL-17-IL-6-Stat3 Axis Promotes Tumor Growth in Murine Models of Melanoma
Tang, Q., Li, J., Zhu, H., Li, P., Zou, Z., & Xiao, Y. (2013) · Mediators of Inflammation · doi:10.1155/2013/713859 · Cited by 69
“IL-17 is an inflammatory cytokine which plays an important role in the regulation of leukocyte migration in inflammatory reaction [4–8].”
BackgroundBishu, S., Hernández-Santos, N., Simpson-Abelson, M. R., Huppler, A. R., Conti, H. R., Ghilardi, N., Mamo, A. J., & Gaffen, S. L. (2014) · Infection and Immunity · doi:10.1128/iai.01335-13 · Cited by 64
Self-citationTian, X., Wei, W., Cao, Y., Ao, T., Huang, F., Javed, R., Wang, X., Fan, J., Zhang, Y., Liu, Y., et al. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17086 · Cited by 64
Batalla, A., Coto, E., González‐Lara, L., González-Fernández, D., Gómez, J., Fernández-Aranguren, T., Queiró, R., Santos‐Juanes, J., López‐Larrea, C., & Coto‐Segura, P. (2015) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2015.06.011 · Cited by 76
“IL17E also has inhibitory properties over Th17 cells [15].”
Background
Metadata
- Authors
- Gaffen, S. L.
- Affiliations
- University of Pittsburgh (US)
- Corresponding author
- Gaffen, Sarah L.
- ORCID
- Gaffen, Sarah L.
- Venue
- Nature reviews. Immunology
- Published
- 2009-07-03
- Volume
- 9
- Issue
- 8
- Pages
- 556-567
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- PMC
- PMC2821718
- OpenAlex
- W2020233428
- Cited by
- 1,475
- References
- 111
- Citations by year
- 2026: 66 · 2025: 87 · 2024: 57 · 2023: 76 · 2022: 80 · 2021: 118 · 2020: 76 · 2019: 96 · 2018: 81 · 2017: 92 · 2016: 108 · 2015: 91 · 2014: 107 · 2013: 89 · 2012: 90
- FWCI
- 7.31
- Type
- journal article
- Language
- en
- Update notices
- erratum (2009-08-07)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR054389)
- National Institute of Dental and Craniofacial Research (R21DE018822)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- IL-17A, IL-17RA, Th17 cells, cytokine signaling, signal transduction, innate and adaptive immunity, autoimmune disease, inflammatory pathology
- MeSH terms
- Animals, Autoimmune Diseases, T-Lymphocytes, Helper-Inducer, Humans, Inflammation, Signal Transduction, Cytokines, Interleukin-17, Receptors, Interleukin-17
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.